HomeNURL • CNSX
add
Neural Therapeutics Inc
Previous close
$0.020
Day range
$0.020 - $0.020
Year range
$0.010 - $0.050
Market cap
3.37M CAD
Avg Volume
249.90K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.45K | -44.85% |
Net income | -64.50K | 35.89% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 114.80K | 74.49% |
Total assets | 1.98M | 1,935.78% |
Total liabilities | 938.26K | 7.33% |
Total equity | 1.04M | — |
Shares outstanding | 157.40M | — |
Price to book | 2.00 | — |
Return on assets | -12.75% | — |
Return on capital | -15.11% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -64.50K | 35.89% |
Cash from operations | -50.58K | -4,967.84% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -50.58K | -4,967.84% |
Free cash flow | -41.66K | -244.12% |
About
Founded
2020
Headquarters
Website
